These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33739906)

  • 1. Nanodelivery of triamcinolone acetonide with PLGA-chitosan nanoparticles for the treatment of ocular inflammation.
    Xing Y; Zhu L; Zhang K; Li T; Huang S
    Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):308-316. PubMed ID: 33739906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and
    Safwat MA; Mansour HF; Hussein AK; Abdelwahab S; Soliman GM
    Drug Deliv; 2020 Dec; 27(1):1115-1124. PubMed ID: 32720545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis.
    Guo D; Li Q; Sun Y; Guo J; Zhao Q; Yin X; Wei H; Wu S; Bi H
    Nanotechnology; 2019 Apr; 30(16):165702. PubMed ID: 30641491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium.
    Arafa MG; Girgis GNS; El-Dahan MS
    Int J Nanomedicine; 2020; 15():1335-1347. PubMed ID: 32184589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLGA Nanoparticle Platform for Trans-Ocular Barrier to Enhance Drug Delivery: A Comparative Study Based on the Application of Oligosaccharides in the Outer Membrane of Carriers.
    Jiang G; Jia H; Qiu J; Mo Z; Wen Y; Zhang Y; Wen Y; Xie Q; Ban J; Lu Z; Chen Y; Wu H; Ni Q; Chen F; Lu J; Wang Z; Li H; Chen J
    Int J Nanomedicine; 2020; 15():9373-9387. PubMed ID: 33262593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
    Formica ML; Ullio Gamboa GV; Tártara LI; Luna JD; Benoit JP; Palma SD
    Int J Pharm; 2020 Jan; 573():118795. PubMed ID: 31682964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer Nanoparticles with 2-HP-β-Cyclodextrin for Enhanced Retention of Uptake into HCE-T Cells.
    Qin Z; Li B; Deng Q; Wen Y; Feng S; Duan C; Zhao B; Li H; Gao Y; Ban J
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A biodegradable drug delivery system for the treatment of postoperative inflammation.
    Eperon S; Bossy-Nobs L; Petropoulos IK; Gurny R; Guex-Crosier Y
    Int J Pharm; 2008 Mar; 352(1-2):240-7. PubMed ID: 18093765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
    Song X; Wang J; Xu Y; Shao H; Gu J
    Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis.
    Li W; He B; Dai W; Zhang Q; Liu Y
    Int Ophthalmol; 2014 Jun; 34(3):465-76. PubMed ID: 23868505
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Zhang L; Yang S; Wong LR; Xie H; Ho PC
    Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative pilot study of oral diacerein and locally treated diacerein-loaded nanoparticles in a model of osteoarthritis.
    Jung JH; Kim SE; Kim HJ; Park K; Song GG; Choi SJ
    Int J Pharm; 2020 May; 581():119249. PubMed ID: 32217157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
    Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
    Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability of a newly developed bioassay for determining bioactivity of anti-inflammatory compounds in release studies--celecoxib and triamcinolone acetonide released from novel PLGA-based microspheres.
    Yang HY; van Dijk M; Licht R; Beekhuizen M; van Rijen M; Janstål MK; Öner FC; Dhert WJ; Schumann D; Creemers LB
    Pharm Res; 2015 Feb; 32(2):680-90. PubMed ID: 25163981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable scleral implants as new triamcinolone acetonide delivery systems.
    Felt-Baeyens O; Eperon S; Mora P; Limal D; Sagodira S; Breton P; Simonazzi B; Bossy-Nobs L; Guex-Crosier Y; Gurny R
    Int J Pharm; 2006 Sep; 322(1-2):6-12. PubMed ID: 16824708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
    Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
    Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directing the nanoparticle formation by the combination with small molecular assembly and polymeric assembly for topical suppression of ocular inflammation.
    Huang J; Yu X; Zhou Y; Zhang R; Song Q; Wang Q; Li X
    Int J Pharm; 2018 Nov; 551(1-2):223-231. PubMed ID: 30213683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation-enhanced biocompatibility of the supramolecular hydrogel of an anti-inflammatory drug for topical suppression of inflammation.
    Xiong T; Li X; Zhou Y; Song Q; Zhang R; Lei L; Li X
    Acta Biomater; 2018 Jun; 73():275-284. PubMed ID: 29660509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
    Salama AH; Mahmoud AA; Kamel R
    AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.